Insider Selling: Intuitive Surgical (NASDAQ:ISRG) EVP Sells $51,938.25 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $494.65, for a total value of $51,938.25. Following the completion of the sale, the executive vice president directly owned 830 shares in the company, valued at $410,559.50. This trade represents a 11.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Wednesday, February 11th, Myriam Curet sold 421 shares of Intuitive Surgical stock. The shares were sold at an average price of $494.96, for a total value of $208,378.16.
• On Thursday, January 29th, Myriam Curet sold 126 shares of Intuitive Surgical stock. The shares were sold at an average price of $520.02, for a total value of $65,522.52.
• On Tuesday, January 27th, Myriam Curet sold 230 shares of Intuitive Surgical stock. The stock was sold at an average price of $532.61, for a total value of $122,500.30.
• On Wednesday, December 10th, Myriam Curet sold 104 shares of Intuitive Surgical stock. The stock was sold at an average price of $559.90, for a total value of $58,229.60.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $485.84 on Friday. The stock has a 50 day moving average price of $541.62 and a 200-day moving average price of $510.24. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $609.08. The company has a market capitalization of $172.54 billion, a P/E ratio of 61.58, a P/E/G ratio of 3.71 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the prior year, the firm earned $2.21 earnings per share. Intuitive Surgical’s revenue was up 18.8% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Institutional Trading of Intuitive Surgical

Large investors have recently made changes to their positions in the stock. Tobam lifted its holdings in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares in the last quarter. Holos Integrated Wealth LLC bought a new position in Intuitive Surgical in the 4th quarter worth about $25,000. Newbridge Financial Services Group Inc. increased its position in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares during the period. Kilter Group LLC bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $27,000. Finally, Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $27,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on ISRG shares. Rothschild & Co Redburn boosted their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Sanford C. Bernstein boosted their target price on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. Jefferies Financial Group increased their price target on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. HSBC lifted their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research note on Monday, January 26th. Finally, Barclays set a $712.00 target price on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $617.23.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.